Emory University Purchases Corning(R) Epic(R) System

Corning Incorporated (NYSE: GLW) today announced that Emory University purchased the label-free Corning® Epic® System to integrate into its extensive drug discovery program at the Emory Chemical Biology Discovery Center (ECBDC). This technology will enable ECBDC to further develop chemical tools for biological research and drive the discovery of new drug compounds which may lead to new therapeutics for disease.

ECBDC is part of the Molecular Libraries Screening Centers Network (MLSCN), which is funded by the National Institutes of Health (NIH). The MLSCN consists of 10 screening centers focused on discovering new chemical probes via a diverse set of screening platform technologies. It also serves Emory investigators, as well as off-campus collaborators, for their small molecule lead discovery needs.

"Emory's decision to purchase the Corning Epic System highlights the significant potential of label-free technology in drug discovery," said Ron Verkleeren, business director, Corning Epic System. "Epic's ability to non-invasively monitor the real-time responses of small molecular compounds in living cells will provide Emory with valuable insights which could streamline their search for new drugs."

The Corning Epic System is the world's first high-throughput, label-free screening system. It is able to perform biochemical and cell-based assays without the addition of radioactive or fluorescent dyes, which may interfere with biochemical interactions. It uses patented optical biosensors technology to measure a broad range of biological responses that are undetectable with conventional methods.

For additional information on the Epic System or any other Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States, (+1) 978-635-2200 internationally, or visit